{"id":9257,"date":"2024-01-18T20:10:14","date_gmt":"2024-01-18T17:10:14","guid":{"rendered":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"modified":"2024-01-18T20:10:14","modified_gmt":"2024-01-18T17:10:14","slug":"le-traitement-recoveryix-base-sur-la-neurotechnologie-offre-une-alternative-plus-sure-aux-medicaments-pour-les-patients-atteints-daccident-vasculaire-cerebral-et-de-sclerose-en-plaques","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/fr\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","title":{"rendered":"Le traitement RecoveriX bas\u00e9 sur la neurotechnologie offre une alternative plus s\u00fbre aux m\u00e9dicaments pour les patients atteints d'accident vasculaire c\u00e9r\u00e9bral et de SEP"},"content":{"rendered":"
<\/div>\n

Avec de plus en plus de personnes souffrant de maladies neurologiques telles que les accidents vasculaires c\u00e9r\u00e9braux et la scl\u00e9rose en plaques (SEP) chaque ann\u00e9e, la sensibilisation \u00e0 ces maladies et \u00e0 la mani\u00e8re de les traiter ou de les g\u00e9rer est devenue plus importante. Selon l'Organisation mondiale de la sant\u00e9, le risque au cours de la vie de d\u00e9velopper un accident vasculaire c\u00e9r\u00e9bral a augment\u00e9. augment\u00e9 de 50% au cours des 17 derni\u00e8res ann\u00e9es<\/span><\/a>, avec environ une personne sur quatre susceptible de subir un accident vasculaire c\u00e9r\u00e9bral au cours de sa vie. Entre-temps, pr\u00e8s de 3 millions de personnes <\/span><\/a>personnes atteintes de SEP dans le monde.<\/p>\n

Les patients victimes d\u2019un AVC ou de SEP se retrouvent souvent avec une qualit\u00e9 de vie r\u00e9duite, en raison de mouvements limit\u00e9s et d\u2019une spasticit\u00e9 musculaire, en particulier au niveau des membres. La plupart des m\u00e9dicaments administr\u00e9s aux patients sont incapables de restaurer les fonctions corporelles affect\u00e9es. Au lieu de cela, ceux-ci ne peuvent qu'emp\u00eacher la d\u00e9t\u00e9rioration de l'\u00e9tat du patient ou, dans le cas de la SEP, ralentir son d\u00e9clin. Les m\u00e9dicaments antispastiques oraux ont souvent des effets limit\u00e9s et peut provoquer des effets secondaires<\/span><\/a> comme la faiblesse, la confusion et les \u00e9tourdissements. Chez certains patients, de petites doses de toxine botulique (botox) sont inject\u00e9es dans les muscles pour soulager la spasticit\u00e9. Ce traitement n\u2019est efficace que pendant environ 12 semaines, avant de devoir \u00eatre r\u00e9p\u00e9t\u00e9, ce qui peut \u00eatre \u00e0 la fois co\u00fbteux et risqu\u00e9.<\/p>\n

Contrairement \u00e0 la plupart des m\u00e9dicaments contre les accidents vasculaires c\u00e9r\u00e9braux et la SEP disponibles sur le march\u00e9, r\u00e9cup\u00e9rerX<\/span><\/a>, un traitement de neuror\u00e9adaptation \u00e0 l'interface cerveau-ordinateur, s'est av\u00e9r\u00e9 utile \u00e0 la r\u00e9\u00e9ducation des accident vasculaire c\u00e9r\u00e9bral<\/span><\/a> et scl\u00e9rose en plaques<\/span><\/a> les patients. D\u00e9velopp\u00e9 par une soci\u00e9t\u00e9 bas\u00e9e en Autriche ing\u00e9nierie m\u00e9dicale g.tec<\/span><\/a>, recoveryiX stimule \u00e9lectriquement les membres des patients, les aidant ainsi \u00e0 retrouver leur fonction apr\u00e8s avoir \u00e9t\u00e9 alt\u00e9r\u00e9s par des troubles neurologiques. Le patient est assis devant une unit\u00e9 informatique et porte un casque EEG qui lit les ondes c\u00e9r\u00e9brales du patient. Le moniteur sert de guide de mouvement pour leurs membres et les \u00e9lectrodes connect\u00e9es \u00e0 leurs membres fournissent une stimulation \u00e9lectrique aux muscles, provoquant une dorsiflexion des articulations. Chaque s\u00e9ance de th\u00e9rapie dure environ une heure, avec un bloc de traitement recoveryiX compos\u00e9 de 25 s\u00e9ances, id\u00e9alement trois fois par semaine.<\/p>\n

Utilisation r\u00e9p\u00e9t\u00e9e de recoveryiX <\/span><\/a>Il a \u00e9t\u00e9 d\u00e9montr\u00e9 qu'il aide les patients \u00e0 retrouver l'usage de leurs membres, avec une spasticit\u00e9 r\u00e9duite et une motricit\u00e9 am\u00e9lior\u00e9e. Par exemple, cela peut \u00eatre d\u00e9montr\u00e9<\/span><\/a> par de meilleures performances au test de cheville \u00e0 neuf trous, une mesure de la dext\u00e9rit\u00e9 manuelle fine. Les patients ont \u00e9galement montr\u00e9 une meilleure concentration, de meilleures performances physiques, une meilleure cognition, une meilleure m\u00e9moire et un meilleur contr\u00f4le de la vessie. Ceux-ci contribuent \u00e0 am\u00e9liorer la qualit\u00e9 de vie et permettent aux patients de r\u00e9aliser la plupart des activit\u00e9s qu'ils ne pouvaient pas faire apr\u00e8s un accident vasculaire c\u00e9r\u00e9bral ou une SEP.<\/p>\n

Selon le Dr Christoph Guger, co-fondateur et PDG de g.tec, recoveryiX, qui repose sur la stimulation visuelle et \u00e9lectromusculaire, a de multiples effets positifs sans aucun effet secondaire n\u00e9gatif significatif. Il ajoute qu'en regardant les \u00e9tudes cliniques sur les m\u00e9dicaments, il faut que des milliers de patients prouvent que le m\u00e9dicament a un certain effet. \u00c9tant donn\u00e9 que l\u2019essai clinique implique des tests sur un grand nombre de personnes, cela ne signifie pas que le m\u00e9dicament est id\u00e9al pour un patient individuel.<\/p>\n

Par ailleurs, pour la scl\u00e9rose en plaques, il existe une vingtaine de m\u00e9dicaments diff\u00e9rents qui peuvent \u00eatre utilis\u00e9s, selon le patient et le type de SEP. Apr\u00e8s un an de prise d'un certain m\u00e9dicament, le patient est \u00e9valu\u00e9 pour savoir s'il est efficace. Si le m\u00e9dicament n'est pas adapt\u00e9 au patient, il est possible que cela ne fasse qu'empirer les choses, explique Guger.<\/p>\n

Malgr\u00e9 l\u2019\u00e9norme impact positif des nouveaux traitements technologiques tels que recoveryiX, Guger note que les m\u00e9decins peuvent parfois h\u00e9siter \u00e0 les prescrire. Certaines compagnies d\u2019assurance ne couvrent pas encore ces traitements. Selon Guger, cela est d\u00fb au fait que de nombreux m\u00e9decins \u00e9taient form\u00e9s uniquement aux m\u00e9dicaments et que recoveryiX n'existait pas encore lorsqu'ils \u00e9taient \u00e0 la facult\u00e9 de m\u00e9decine. Cependant, avec le temps, il pense que davantage de professionnels de la sant\u00e9 verront les avantages de recoveryiX et l'associeront \u00e0 leurs m\u00e9dicaments et \u00e0 leurs sch\u00e9mas th\u00e9rapeutiques. De plus, les compagnies d'assurance commenceront \u00e0 couvrir les sessions recoveryiX une fois qu'elles auront constat\u00e9 que cela fonctionne et entra\u00eenera une r\u00e9duction des co\u00fbts d'indemnisation de l'assurance.<\/p>\n

Aujourd'hui, recoveryiX est disponible dans plusieurs pays d'Europe, d'Asie-Pacifique, d'Am\u00e9rique du Nord et d'Afrique et g.tec utilise un syst\u00e8me de franchise unique pour permettre la diffusion rapide de la technologie. Guger se bat pour garantir qu'un plus grand nombre de personnes souffrant d'accidents vasculaires c\u00e9r\u00e9braux, de SEP et d'autres maladies neurologiques puissent acc\u00e9der \u00e0 recoveryiX et constater par elles-m\u00eames ses effets positifs, ainsi que faire passer le message \u00e0 d'autres personnes qui en ont besoin.<\/p>\n

Source quotidienne m\u00e9dicale<\/a><\/p>\n

","protected":false},"excerpt":{"rendered":"

<\/div>\n

Avec de plus en plus de personnes souffrant de maladies neurologiques telles que les accidents vasculaires c\u00e9r\u00e9braux et la scl\u00e9rose en plaques (SEP) chaque ann\u00e9e, la sensibilisation \u00e0 ces maladies et \u00e0 la mani\u00e8re de les traiter ou de les g\u00e9rer est devenue plus importante. Selon l'Organisation mondiale de la sant\u00e9, le risque au cours de la vie de d\u00e9velopper un accident vasculaire c\u00e9r\u00e9bral a augment\u00e9. augment\u00e9 de 50% au cours des 17 derni\u00e8res ann\u00e9es<\/span><\/a>, avec environ une personne sur quatre susceptible de subir un accident vasculaire c\u00e9r\u00e9bral au cours de sa vie. Entre-temps, pr\u00e8s de 3 millions de personnes <\/span><\/a>personnes atteintes de SEP dans le monde.<\/p>\n

Les patients victimes d\u2019un AVC ou de SEP se retrouvent souvent avec une qualit\u00e9 de vie r\u00e9duite, en raison de mouvements limit\u00e9s et d\u2019une spasticit\u00e9 musculaire, en particulier au niveau des membres. La plupart des m\u00e9dicaments administr\u00e9s aux patients sont incapables de restaurer les fonctions corporelles affect\u00e9es. Au lieu de cela, ceux-ci ne peuvent qu'emp\u00eacher la d\u00e9t\u00e9rioration de l'\u00e9tat du patient ou, dans le cas de la SEP, ralentir son d\u00e9clin. Les m\u00e9dicaments antispastiques oraux ont souvent des effets limit\u00e9s et peut provoquer des effets secondaires<\/span><\/a> comme la faiblesse, la confusion et les \u00e9tourdissements. Chez certains patients, de petites doses de toxine botulique (botox) sont inject\u00e9es dans les muscles pour soulager la spasticit\u00e9. Ce traitement n\u2019est efficace que pendant environ 12 semaines, avant de devoir \u00eatre r\u00e9p\u00e9t\u00e9, ce qui peut \u00eatre \u00e0 la fois co\u00fbteux et risqu\u00e9.<\/p>\n

Contrairement \u00e0 la plupart des m\u00e9dicaments contre les accidents vasculaires c\u00e9r\u00e9braux et la SEP disponibles sur le march\u00e9, r\u00e9cup\u00e9rerX<\/span><\/a>, un traitement de neuror\u00e9adaptation \u00e0 l'interface cerveau-ordinateur, s'est av\u00e9r\u00e9 utile \u00e0 la r\u00e9\u00e9ducation des accident vasculaire c\u00e9r\u00e9bral<\/span><\/a> et scl\u00e9rose en plaques<\/span><\/a> les patients. D\u00e9velopp\u00e9 par une soci\u00e9t\u00e9 bas\u00e9e en Autriche ing\u00e9nierie m\u00e9dicale g.tec<\/span><\/a>, recoveryiX stimule \u00e9lectriquement les membres des patients, les aidant ainsi \u00e0 retrouver leur fonction apr\u00e8s avoir \u00e9t\u00e9 alt\u00e9r\u00e9s par des troubles neurologiques. Le patient est assis devant une unit\u00e9 informatique et porte un casque EEG qui lit les ondes c\u00e9r\u00e9brales du patient. Le moniteur sert de guide de mouvement pour leurs membres et les \u00e9lectrodes connect\u00e9es \u00e0 leurs membres fournissent une stimulation \u00e9lectrique aux muscles, provoquant une dorsiflexion des articulations. Chaque s\u00e9ance de th\u00e9rapie dure environ une heure, avec un bloc de traitement recoveryiX compos\u00e9 de 25 s\u00e9ances, id\u00e9alement trois fois par semaine.<\/p>\n

Utilisation r\u00e9p\u00e9t\u00e9e de recoveryiX <\/span><\/a>Il a \u00e9t\u00e9 d\u00e9montr\u00e9 qu'il aide les patients \u00e0 retrouver l'usage de leurs membres, avec une spasticit\u00e9 r\u00e9duite et une motricit\u00e9 am\u00e9lior\u00e9e. Par exemple, cela peut \u00eatre d\u00e9montr\u00e9<\/span><\/a> par de meilleures performances au test de cheville \u00e0 neuf trous, une mesure de la dext\u00e9rit\u00e9 manuelle fine. Les patients ont \u00e9galement montr\u00e9 une meilleure concentration, de meilleures performances physiques, une meilleure cognition, une meilleure m\u00e9moire et un meilleur contr\u00f4le de la vessie. Ceux-ci contribuent \u00e0 am\u00e9liorer la qualit\u00e9 de vie et permettent aux patients de r\u00e9aliser la plupart des activit\u00e9s qu'ils ne pouvaient pas faire apr\u00e8s un accident vasculaire c\u00e9r\u00e9bral ou une SEP.<\/p>\n

Selon le Dr Christoph Guger, co-fondateur et PDG de g.tec, recoveryiX, qui repose sur la stimulation visuelle et \u00e9lectromusculaire, a de multiples effets positifs sans aucun effet secondaire n\u00e9gatif significatif. Il ajoute qu'en regardant les \u00e9tudes cliniques sur les m\u00e9dicaments, il faut que des milliers de patients prouvent que le m\u00e9dicament a un certain effet. \u00c9tant donn\u00e9 que l\u2019essai clinique implique des tests sur un grand nombre de personnes, cela ne signifie pas que le m\u00e9dicament est id\u00e9al pour un patient individuel.<\/p>\n

Par ailleurs, pour la scl\u00e9rose en plaques, il existe une vingtaine de m\u00e9dicaments diff\u00e9rents qui peuvent \u00eatre utilis\u00e9s, selon le patient et le type de SEP. Apr\u00e8s un an de prise d'un certain m\u00e9dicament, le patient est \u00e9valu\u00e9 pour savoir s'il est efficace. Si le m\u00e9dicament n'est pas adapt\u00e9 au patient, il est possible que cela ne fasse qu'empirer les choses, explique Guger.<\/p>\n

Malgr\u00e9 l\u2019\u00e9norme impact positif des nouveaux traitements technologiques tels que recoveryiX, Guger note que les m\u00e9decins peuvent parfois h\u00e9siter \u00e0 les prescrire. Certaines compagnies d\u2019assurance ne couvrent pas encore ces traitements. Selon Guger, cela est d\u00fb au fait que de nombreux m\u00e9decins \u00e9taient form\u00e9s uniquement aux m\u00e9dicaments et que recoveryiX n'existait pas encore lorsqu'ils \u00e9taient \u00e0 la facult\u00e9 de m\u00e9decine. Cependant, avec le temps, il pense que davantage de professionnels de la sant\u00e9 verront les avantages de recoveryiX et l'associeront \u00e0 leurs m\u00e9dicaments et \u00e0 leurs sch\u00e9mas th\u00e9rapeutiques. De plus, les compagnies d'assurance commenceront \u00e0 couvrir les sessions recoveryiX une fois qu'elles auront constat\u00e9 que cela fonctionne et entra\u00eenera une r\u00e9duction des co\u00fbts d'indemnisation de l'assurance.<\/p>\n

Aujourd'hui, recoveryiX est disponible dans plusieurs pays d'Europe, d'Asie-Pacifique, d'Am\u00e9rique du Nord et d'Afrique et g.tec utilise un syst\u00e8me de franchise unique pour permettre la diffusion rapide de la technologie. Guger se bat pour garantir qu'un plus grand nombre de personnes souffrant d'accidents vasculaires c\u00e9r\u00e9braux, de SEP et d'autres maladies neurologiques puissent acc\u00e9der \u00e0 recoveryiX et constater par elles-m\u00eames ses effets positifs, ainsi que faire passer le message \u00e0 d'autres personnes qui en ont besoin.<\/p>","protected":false},"author":2,"featured_media":9258,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"page_builder":"","fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","fifu_image_alt":"","footnotes":""},"categories":[27],"tags":[],"class_list":["post-9257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"\nNeurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/fr\/le-traitement-recoveryix-base-sur-la-neurotechnologie-offre-une-alternative-plus-sure-aux-medicaments-pour-les-patients-atteints-daccident-vasculaire-cerebral-et-de-sclerose-en-plaques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/fr\/le-traitement-recoveryix-base-sur-la-neurotechnologie-offre-une-alternative-plus-sure-aux-medicaments-pour-les-patients-atteints-daccident-vasculaire-cerebral-et-de-sclerose-en-plaques\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-18T17:10:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\"},\"headline\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"wordCount\":727,\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"articleSection\":[\"Medical Daily\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"caption\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/urbancare.clinic\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urbancare.clinic\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\\\/\\\/urbancare.clinic\\\/fr\\\/author\\\/urban-care-clinic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le traitement RecoveriX bas\u00e9 sur la neurotechnologie offre une alternative plus s\u00fbre aux m\u00e9dicaments pour les patients atteints d'accident vasculaire c\u00e9r\u00e9bral et de SEP - Urban Care Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/fr\/le-traitement-recoveryix-base-sur-la-neurotechnologie-offre-une-alternative-plus-sure-aux-medicaments-pour-les-patients-atteints-daccident-vasculaire-cerebral-et-de-sclerose-en-plaques\/","og_locale":"fr_FR","og_type":"article","og_title":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic","og_description":"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.","og_url":"https:\/\/urbancare.clinic\/fr\/le-traitement-recoveryix-base-sur-la-neurotechnologie-offre-une-alternative-plus-sure-aux-medicaments-pour-les-patients-atteints-daccident-vasculaire-cerebral-et-de-sclerose-en-plaques\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2024-01-18T17:10:14+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","width":1024,"height":1024,"type":"image\/jpeg"}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Urban Care Clinic","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930"},"headline":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients","datePublished":"2024-01-18T17:10:14+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"wordCount":727,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","articleSection":["Medical Daily"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","url":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","name":"Le traitement RecoveriX bas\u00e9 sur la neurotechnologie offre une alternative plus s\u00fbre aux m\u00e9dicaments pour les patients atteints d'accident vasculaire c\u00e9r\u00e9bral et de SEP - Urban Care Clinic","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","datePublished":"2024-01-18T17:10:14+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","caption":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"Clinique de soins urbains","description":"Votre clinique de soins m\u00e9dicaux \u00e0 Zanzibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Clinique de soins urbains Zanzibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930","name":"Clinique de soins urbains","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/fr\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts\/9257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/comments?post=9257"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts\/9257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/media\/9258"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/media?parent=9257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/categories?post=9257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/tags?post=9257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}